Clinical trial
High Dose Candesartan Versus Quinapril for Restenosis Prophylaxis After Stent…
NCT00154050 · Technische Universität Dresden, Other · Completed
Key facts
| NCT number | NCT00154050 |
|---|---|
| Title | High Dose Candesartan Versus Quinapril for Restenosis Prophylaxis After Stent Angioplasty |
| Lead sponsor | Technische Universität Dresden, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Arterial Occlusive Diseases |
| Intervention type | Drug |
| Interventions | candesartan (drug) or quinapril (drug) |
| Enrollment | 22 |
| Start date | May 1, 2004 |
| Completion | Jul 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 12, 2006 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: